H Zäske1, D Degner2, M Jockers-Scherübl3, S Klingberg4, J Klosterkötter5, W Maier6, H-J Möller7, H Sauer8, A Schmitt7,9, W Gaebel10. 1. Klinik und Poliklinik für Psychiatrie und Psychotherapie, Medizinische Fakultät, LVR-Klinikum Düsseldorf, Heinrich-Heine Universität, Bergische Landstr. 2, 40629, Düsseldorf, Deutschland. harald.zaeske@lvr.de. 2. Klinik für Psychiatrie und Psychotherapie, Universitätsmedizin Göttingen, Göttingen, Deutschland. 3. Klinik Hennigsdorf, Oberhavel Kliniken GmbH, Hennigsdorf, Deutschland. 4. Universitätsklinik für Psychiatrie und Psychotherapie Tübingen, Tübingen, Deutschland. 5. Klinik und Poliklinik für Psychiatrie und Psychotherapie, Universitätsklinikum Köln, Köln, Deutschland. 6. Klinik und Poliklinik für Psychiatrie und Psychotherapie, Universitätsklinikum Bonn, Bonn, Deutschland. 7. Klinik für Psychiatrie und Psychotherapie, Ludwig-Maximilians-Universität München, München, Deutschland. 8. Klinik für Psychiatrie und Psychotherapie, Universitätsklinikum Jena, Jena, Deutschland. 9. Zentralinstitut für Seelische Gesundheit, Mannheim, Deutschland. 10. Klinik und Poliklinik für Psychiatrie und Psychotherapie, Medizinische Fakultät, LVR-Klinikum Düsseldorf, Heinrich-Heine Universität, Bergische Landstr. 2, 40629, Düsseldorf, Deutschland.
Abstract
BACKGROUND: Patients with mental illnesses, especially with schizophrenia, suffer from stigma and discrimination. In addition, the stigma is a barrier to recognising and treating patients with first-episode psychosis; however, a self-rating instrument that assesses the general burden due to stigma experiences is still lacking. MATERIAL AND METHODS: A total of N = 48 patients with first-episode schizophrenia who were participants in the multicenter first-episode (long-term) study within the German Research Network on Schizophrenia, completed a newly developed self-rating questionnaire to assess the burden due to stigma experiences (B-STE). The following variables were analyzed as possible correlates: psychopathology (CGI, PANSS, CDSS and HAM-D), global functioning (GAF), social adjustment (SAS), self-esteem (FSKN), as well as quality of life (LQLP), subjective well-being under neuroleptic treatment (SWN) and anticipated stigma (PDDQ). RESULTS: Of the participants 25 % showed an increased burden due to stigma experiences, which correlated with a lower quality of life, lower subjective well-being under neuroleptic treatment, lower self-esteem and higher anticipated stigma. The results indicate that patients rated higher on the CGI scale who are at the same time better socially adjusted (SAS), are more intensely affected by the burden due to stigma experiences. CONCLUSION: The short self-rating instrument burden due to stigma experiences (B-STE) can help to identify patients who might benefit from therapeutic or educational interventions to support coping with stigma experiences.
BACKGROUND:Patients with mental illnesses, especially with schizophrenia, suffer from stigma and discrimination. In addition, the stigma is a barrier to recognising and treating patients with first-episode psychosis; however, a self-rating instrument that assesses the general burden due to stigma experiences is still lacking. MATERIAL AND METHODS: A total of N = 48 patients with first-episode schizophrenia who were participants in the multicenter first-episode (long-term) study within the German Research Network on Schizophrenia, completed a newly developed self-rating questionnaire to assess the burden due to stigma experiences (B-STE). The following variables were analyzed as possible correlates: psychopathology (CGI, PANSS, CDSS and HAM-D), global functioning (GAF), social adjustment (SAS), self-esteem (FSKN), as well as quality of life (LQLP), subjective well-being under neuroleptic treatment (SWN) and anticipated stigma (PDDQ). RESULTS: Of the participants 25 % showed an increased burden due to stigma experiences, which correlated with a lower quality of life, lower subjective well-being under neuroleptic treatment, lower self-esteem and higher anticipated stigma. The results indicate that patients rated higher on the CGI scale who are at the same time better socially adjusted (SAS), are more intensely affected by the burden due to stigma experiences. CONCLUSION: The short self-rating instrument burden due to stigma experiences (B-STE) can help to identify patients who might benefit from therapeutic or educational interventions to support coping with stigma experiences.
Entities:
Keywords:
Burden due to stigma experiences; Global functioning; Scale; Self-rating instrument; Stigma
Authors: Gabriel Gerlinger; Marta Hauser; Marc De Hert; Kathleen Lacluyse; Martien Wampers; Christoph U Correll Journal: World Psychiatry Date: 2013-06 Impact factor: 49.548
Authors: E Corker; S Hamilton; C Henderson; C Weeks; V Pinfold; D Rose; P Williams; C Flach; V Gill; E Lewis-Holmes; G Thornicroft Journal: Br J Psychiatry Suppl Date: 2013-04